| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |